Motif Bio Plc (NASDAQ:MTFB) – Equities researchers at Zacks Investment Research issued their Q2 2017 earnings per share estimates for Motif Bio Plc in a note issued to investors on Tuesday. Zacks Investment Research analyst D. Bautz expects that the company will post earnings per share of ($0.80) for the quarter. Zacks Investment Research has a “Hold” rating on the stock. Zacks Investment Research also issued estimates for Motif Bio Plc’s Q3 2017 earnings at ($0.69) EPS, Q4 2017 earnings at ($0.70) EPS, FY2017 earnings at ($3.06) EPS, FY2018 earnings at ($3.38) EPS and FY2019 earnings at ($2.30) EPS.

Separately, HC Wainwright set a $25.00 price objective on shares of Motif Bio Plc and gave the stock a “buy” rating in a research report on Wednesday, August 9th.

TRADEMARK VIOLATION WARNING: This article was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at

Shares of Motif Bio Plc (NASDAQ MTFB) opened at 7.40 on Friday. The company has a 50 day moving average price of $7.36 and a 200 day moving average price of $7.52. The company’s market capitalization is $72.48 million. Motif Bio Plc has a 1-year low of $5.15 and a 1-year high of $14.42.

Receive News & Ratings for Motif Bio Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motif Bio Plc and related companies with's FREE daily email newsletter.